🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 3 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 28/04/2009 | 28,95 | 29,33 | 28,95 | 29,03 | -1,22% | 1,31% | 1.324.200 |
| 27/04/2009 | 28,60 | 29,56 | 28,60 | 29,39 | +1,73% | 3,36% | 887.400 |
| 24/04/2009 | 28,22 | 29,27 | 28,01 | 28,89 | +1,99% | 4,46% | 1.407.400 |
| 23/04/2009 | 28,20 | 28,50 | 27,54 | 28,33 | +0,57% | 3,40% | 1.516.000 |
| 22/04/2009 | 27,70 | 28,72 | 27,46 | 28,17 | +1,11% | 4,53% | 1.458.000 |
| 21/04/2009 | 28,35 | 28,41 | 27,35 | 27,86 | -1,88% | 3,74% | 1.912.400 |
| 20/04/2009 | 29,05 | 29,27 | 28,18 | 28,39 | -5,63% | 3,75% | 1.455.600 |
| 17/04/2009 | 30,22 | 30,67 | 30,01 | 30,09 | -0,08% | 2,20% | 748.400 |
| 16/04/2009 | 30,50 | 30,58 | 29,65 | 30,11 | -0,51% | 3,05% | 1.158.200 |
| 15/04/2009 | 30,97 | 31,42 | 29,90 | 30,27 | -3,14% | 4,89% | 1.955.800 |
| 14/04/2009 | 31,42 | 32,06 | 31,14 | 31,25 | -1,45% | 2,94% | 974.400 |
| 13/04/2009 | 31,46 | 32,31 | 31,46 | 31,71 | -0,64% | 2,70% | 1.155.400 |
| 09/04/2009 | 31,62 | 32,23 | 31,08 | 31,91 | +2,57% | 3,64% | 1.048.200 |
| 08/04/2009 | 31,15 | 31,15 | 30,63 | 31,11 | +0,65% | 1,67% | 687.000 |
| 07/04/2009 | 31,68 | 31,72 | 30,72 | 30,91 | -3,50% | 3,16% | 1.344.800 |
| 06/04/2009 | 32,40 | 32,71 | 31,41 | 32,03 | -1,16% | 4,01% | 1.230.400 |
| 03/04/2009 | 33,07 | 33,24 | 32,08 | 32,41 | -1,74% | 3,51% | 849.400 |
| 02/04/2009 | 33,37 | 33,53 | 32,65 | 32,98 | +0,64% | 2,64% | 975.200 |
| 01/04/2009 | 32,54 | 32,82 | 32,17 | 32,77 | -0,83% | 2,01% | 1.028.200 |
| 31/03/2009 | 33,44 | 33,99 | 32,89 | 33,05 | -0,15% | 3,28% | 2.137.000 |
| 30/03/2009 | 33,03 | 33,35 | 32,60 | 33,10 | -1,06% | 2,27% | 1.070.600 |
| 27/03/2009 | 33,26 | 34,20 | 33,18 | 33,45 | -0,59% | 3,07% | 748.000 |
| 26/03/2009 | 33,33 | 33,79 | 32,76 | 33,65 | +1,32% | 3,08% | 1.330.600 |
| 25/03/2009 | 32,42 | 33,42 | 32,06 | 33,21 | +2,53% | 4,21% | 781.800 |
| 24/03/2009 | 32,17 | 32,75 | 31,82 | 32,39 | +0,09% | 2,89% | 957.200 |
| 23/03/2009 | 31,34 | 32,36 | 30,85 | 32,36 | +4,42% | 4,83% | 994.600 |
| 20/03/2009 | 31,44 | 31,71 | 30,87 | 30,99 | -0,96% | 2,66% | 1.277.400 |
| 19/03/2009 | 31,66 | 31,70 | 31,00 | 31,29 | -0,78% | 2,21% | 837.600 |
| 18/03/2009 | 31,32 | 32,55 | 30,97 | 31,54 | +0,75% | 5,04% | 1.319.600 |
| 17/03/2009 | 29,56 | 31,30 | 29,28 | 31,30 | +4,86% | 6,83% | 1.883.400 |